Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poly-D,L-lactic acid polymer and cochlear implantation.
Di Berardino F, Messina F, Conte G, Cavicchiolo S, Rossi D, Giannì AB, Pignataro L, Zanetti D. Di Berardino F, et al. Among authors: messina f. Clin Case Rep. 2022 Sep 19;10(9):e6355. doi: 10.1002/ccr3.6355. eCollection 2022 Sep. Clin Case Rep. 2022. PMID: 36188030 Free PMC article.
Proximal humerus fractures treatment in adult patients with bone metastasis.
Rovere G, Meschini C, Piazza P, Messina F, Caredda M, De Marco D, Noia G, Maccagnano G, Ziranu A. Rovere G, et al. Among authors: messina f. Eur Rev Med Pharmacol Sci. 2022 Nov;26(1 Suppl):100-105. doi: 10.26355/eurrev_202211_30288. Eur Rev Med Pharmacol Sci. 2022. PMID: 36448865 Free article.
[Treatment of childhood psoriasis: present and future].
Messina F, Conrad C, Morren MA. Messina F, et al. Rev Med Suisse. 2024 Mar 27;20(867):631-635. doi: 10.53738/REVMED.2024.20.867.631. Rev Med Suisse. 2024. PMID: 38563537 Review. French.
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy.
Fassio A, Porciello G, Carioli G, Palumbo E, Vitale S, Luongo A, Montagnese C, Prete M, Grimaldi M, Pica R, Rotondo E, Falzone L, Calabrese I, Minopoli A, Grilli B, Cuomo M, Fiorillo PC, Evangelista C, Cavalcanti E, De Laurentiis M, Cianniello D, Pacilio C, Pinto M, Thomas G, Rinaldo M, D'Aiuto M, Serraino D, Massarut S, Steffan A, Ferraù F, Rossello R, Messina F, Catalano F, Adami G, Bertoldo F, Libra M, Crispo A, Celentano E, La Vecchia C, Augustin LSA, Gatti D. Fassio A, et al. Among authors: messina f. Reumatismo. 2024 Mar 22;76(1). doi: 10.4081/reumatismo.2024.1632. Reumatismo. 2024. PMID: 38523582 Free article. Clinical Trial.
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals.
Peel JN, Yang R, Le Voyer T, Gervais A, Rosain J, Bastard P, Behere A, Cederholm A, Bodansky A, Seeleuthner Y, Conil C, Ding JY, Lei WT, Bizien L, Soudee C, Migaud M, Ogishi M, Yatim A, Lee D, Bohlen J, Perpoint T, Perez L, Messina F, Genet R, Karkowski L, Blot M, Lafont E, Toullec L, Goulvestre C, Mehlal-Sedkaoui S, Sallette J, Martin F, Puel A, Jouanguy E; CONSTANCES cohort; 3C-Dijon Study; Etablissement du Sang study group; Anderson MS, Landegren N, Tiberghien P, Abel L, Boisson-Dupuis S, Bustamante J, Ku CL, Casanova JL. Peel JN, et al. Among authors: messina f. J Clin Invest. 2024 Mar 12;134(8):e178263. doi: 10.1172/JCI178263. J Clin Invest. 2024. PMID: 38470480 Free PMC article.
339 results